<!DOCTYPE html>
<html lang="de">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Fetts√§ure-Oxidationsst√∂rungen - Teil 2</title>
    <style>
        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f8f9fa;
            line-height: 1.6;
        }
        
        .container {
            max-width: 1000px;
            margin: 0 auto;
            background: white;
            box-shadow: 0 0 20px rgba(0,0,0,0.1);
        }
        
        .header {
            background: linear-gradient(135deg, #8e44ad, #e74c3c, #f39c12);
            color: white;
            padding: 40px 30px;
            text-align: center;
            position: relative;
        }
        
        .header::before {
            content: "ü©∫";
            font-size: 3rem;
            display: block;
            margin-bottom: 10px;
        }
        
        .header h1 {
            margin: 0;
            font-size: 2.5rem;
            font-weight: 300;
        }
        
        .header .subtitle {
            font-size: 1.1rem;
            margin-top: 10px;
            opacity: 0.9;
        }
        
        .progress-bar {
            height: 4px;
            background: linear-gradient(90deg, #8e44ad, #e74c3c);
            width: 66%;
        }
        
        .info-box {
            background: linear-gradient(135deg, #e3f2fd, #bbdefb);
            margin: 20px;
            padding: 20px;
            border-radius: 8px;
            border-left: 4px solid #2196f3;
        }
        
        .info-box .icon {
            display: inline-block;
            margin-right: 10px;
            font-size: 1.2rem;
        }
        
        .navigation {
            display: flex;
            flex-wrap: wrap;
            gap: 10px;
            padding: 20px;
            background: #f5f5f5;
        }
        
        .nav-item {
            background: linear-gradient(135deg, #6c757d, #495057);
            color: white;
            padding: 12px 20px;
            border-radius: 25px;
            text-decoration: none;
            font-weight: 500;
            transition: all 0.3s ease;
            border: none;
            cursor: pointer;
        }
        
        .nav-item.active {
            background: linear-gradient(135deg, #e91e63, #ad1457);
        }
        
        .nav-item:hover {
            transform: translateY(-2px);
            box-shadow: 0 5px 15px rgba(0,0,0,0.2);
        }
        
        .content {
            padding: 30px;
        }
        
        .section-header {
            display: flex;
            align-items: center;
            margin-bottom: 30px;
        }
        
        .section-header::before {
            content: "üî¨";
            font-size: 2rem;
            margin-right: 15px;
        }
        
        .section-header h2 {
            color: #8e44ad;
            margin: 0;
            font-size: 1.8rem;
        }
        
        .age-group-container {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 20px;
            margin: 20px 0;
        }
        
        .age-group {
            background: linear-gradient(135deg, #fce4ec, #f8bbd9);
            padding: 25px;
            border-radius: 12px;
            border: 2px solid #e91e63;
        }
        
        .age-group h3 {
            color: #ad1457;
            margin-top: 0;
            display: flex;
            align-items: center;
        }
        
        .age-group.neonatal h3::before { content: "üë∂"; margin-right: 10px; }
        .age-group.infant h3::before { content: "üçº"; margin-right: 10px; }
        .age-group.child h3::before { content: "üßí"; margin-right: 10px; }
        .age-group.adult h3::before { content: "üë®‚Äç‚öïÔ∏è"; margin-right: 10px; }
        
        .symptom-list {
            list-style: none;
            padding-left: 0;
        }
        
        .symptom-list li {
            padding: 8px 0;
            border-bottom: 1px solid rgba(255,255,255,0.3);
            position: relative;
            padding-left: 25px;
        }
        
        .symptom-list li.severe::before {
            content: "üî¥";
            position: absolute;
            left: 0;
            top: 8px;
        }
        
        .symptom-list li.moderate::before {
            content: "üü°";
            position: absolute;
            left: 0;
            top: 8px;
        }
        
        .symptom-list li.mild::before {
            content: "üü¢";
            position: absolute;
            left: 0;
            top: 8px;
        }
        
        .diagnostic-flowchart {
            background: linear-gradient(135deg, #fff3e0, #ffe0b2);
            padding: 25px;
            border-radius: 12px;
            margin: 20px 0;
            border: 2px solid #ff9800;
        }
        
        .diagnostic-flowchart h3 {
            color: #ef6c00;
            margin-top: 0;
            display: flex;
            align-items: center;
        }
        
        .diagnostic-flowchart h3::before {
            content: "üîÑ";
            margin-right: 10px;
        }
        
        .flowchart-step {
            background: white;
            padding: 15px;
            margin: 15px 0;
            border-radius: 8px;
            border-left: 4px solid #ff9800;
            position: relative;
        }
        
        .flowchart-step.decision {
            border-left-color: #2196f3;
            background: #e3f2fd;
        }
        
        .flowchart-step.action {
            border-left-color: #4caf50;
            background: #e8f5e8;
        }
        
        .flowchart-step.warning {
            border-left-color: #f44336;
            background: #ffebee;
        }
        
        .lab-table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
            border-radius: 8px;
            overflow: hidden;
        }
        
        .lab-table th {
            background: linear-gradient(135deg, #8e44ad, #9b59b6);
            color: white;
            padding: 15px;
            text-align: left;
            font-weight: 600;
        }
        
        .lab-table td {
            padding: 12px 15px;
            border-bottom: 1px solid #eee;
        }
        
        .lab-table tr:nth-child(even) {
            background: #f8f9fa;
        }
        
        .lab-table tr:hover {
            background: #e3f2fd;
        }
        
        .case-study {
            background: linear-gradient(135deg, #e8f5e8, #c8e6c9);
            padding: 25px;
            border-radius: 12px;
            margin: 20px 0;
            border: 2px solid #4caf50;
        }
        
        .case-study h3 {
            color: #2e7d32;
            margin-top: 0;
            display: flex;
            align-items: center;
        }
        
        .case-study h3::before {
            content: "üìã";
            margin-right: 10px;
        }
        
        .case-details {
            background: white;
            padding: 15px;
            border-radius: 8px;
            margin: 15px 0;
        }
        
        .differential-box {
            background: linear-gradient(135deg, #f3e5f5, #e1bee7);
            padding: 25px;
            border-radius: 12px;
            margin: 20px 0;
            border: 2px solid #9c27b0;
        }
        
        .differential-box h3 {
            color: #6a1b9a;
            margin-top: 0;
            display: flex;
            align-items: center;
        }
        
        .differential-box h3::before {
            content: "üîç";
            margin-right: 10px;
        }
        
        .differential-item {
            background: white;
            padding: 15px;
            margin: 10px 0;
            border-radius: 8px;
            border-left: 4px solid #9c27b0;
        }
        
        .checklist {
            background: linear-gradient(135deg, #fff8e1, #ffecb3);
            padding: 25px;
            border-radius: 12px;
            margin: 20px 0;
            border: 2px solid #ffc107;
        }
        
        .checklist h3 {
            color: #f57f17;
            margin-top: 0;
            display: flex;
            align-items: center;
        }
        
        .checklist h3::before {
            content: "‚úÖ";
            margin-right: 10px;
        }
        
        .checklist-item {
            display: flex;
            align-items: center;
            padding: 10px 0;
            border-bottom: 1px solid rgba(255,193,7,0.3);
        }
        
        .checklist-item input[type="checkbox"] {
            margin-right: 10px;
            transform: scale(1.2);
        }
        
        .emergency-box {
            background: linear-gradient(135deg, #ffebee, #ffcdd2);
            padding: 25px;
            border-radius: 12px;
            margin: 20px 0;
            border: 2px solid #f44336;
        }
        
        .emergency-box h3 {
            color: #c62828;
            margin-top: 0;
            display: flex;
            align-items: center;
        }
        
        .emergency-box h3::before {
            content: "üö®";
            margin-right: 10px;
        }
        
        .next-section {
            background: linear-gradient(135deg, #8e44ad, #9b59b6);
            color: white;
            padding: 20px;
            border-radius: 8px;
            text-align: center;
            margin-top: 40px;
        }
        
        .next-section h3 {
            margin: 0 0 10px 0;
        }
        
        @media (max-width: 768px) {
            .header {
                padding: 30px 20px;
            }
            
            .header h1 {
                font-size: 2rem;
            }
            
            .content {
                padding: 20px;
            }
            
            .navigation {
                flex-direction: column;
            }
            
            .age-group-container {
                grid-template-columns: 1fr;
            }
            
            .lab-table {
                font-size: 0.9rem;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <header class="header">
            <h1>Fetts√§ure-Oxidationsst√∂rungen</h1>
            <div class="subtitle">Teil 2: Klinische Pr√§sentation & Diagnostik</div>
        </header>
        
        <div class="progress-bar"></div>
        
        <div class="info-box">
            <span class="icon">üî¨</span>
            <strong>Lerneinheit Teil 2</strong><br>
            Dieser Teil behandelt die altersabh√§ngigen klinischen Manifestationen, diagnostischen Algorithmen und Laborparameter f√ºr eine sichere Diagnosestellung in der klinischen Praxis.
        </div>
        
        <nav class="navigation">
            <button class="nav-item" onclick="alert('Teil 1: Grundlagen & Pathophysiologie')">1. GRUNDLAGEN</button>
            <button class="nav-item active">2. KLINISCHE PR√ÑSENTATION</button>
            <button class="nav-item active">3. DIAGNOSTIK</button>
            <button class="nav-item" onclick="alert('Teil 3 folgt: Therapie & Notfallmanagement')">4. THERAPIE</button>
            <button class="nav-item" onclick="alert('Teil 3 folgt: Therapie & Notfallmanagement')">5. NOTFALLMANAGEMENT</button>
        </nav>
        
        <main class="content">
            <div class="section-header">
                <h2>Klinische Pr√§sentation nach Altersgruppen</h2>
            </div>
            
            <div class="age-group-container">
                <div class="age-group neonatal">
                    <h3>Neonatalperiode (0-28 Tage)</h3>
                    <ul class="symptom-list">
                        <li class="severe"><strong>Schwere Hypoglyk√§mie</strong> (oft hypoketon)</li>
                        <li class="severe"><strong>Hyperammon√§mie</strong> (>100 Œºmol/L)</li>
                        <li class="severe"><strong>Metabolische Azidose</strong></li>
                        <li class="severe"><strong>Hepatomegalie mit Leberfunktionsst√∂rung</strong></li>
                        <li class="moderate"><strong>Kardiomyopathie</strong> (VLCAD, LCHAD/TFP)</li>
                        <li class="moderate"><strong>Lethargie, Trinkschw√§che</strong></li>
                        <li class="mild">Hypothermie</li>
                        <li class="mild">Gedeihst√∂rung</li>
                    </ul>
                    <div style="margin-top: 15px; padding: 10px; background: rgba(255,255,255,0.7); border-radius: 5px;">
                        <strong>Typisch f√ºr:</strong> VLCAD (schwere Form), LCHAD/TFP, MADD
                    </div>
                </div>
                
                <div class="age-group infant">
                    <h3>S√§uglingsalter (1-12 Monate)</h3>
                    <ul class="symptom-list">
                        <li class="severe"><strong>Hypoketon Hypoglyk√§mie</strong> bei Fasten/Fieber</li>
                        <li class="severe"><strong>Pl√∂tzlicher Kindstod (SIDS)</strong></li>
                        <li class="moderate"><strong>Hepatomegalie</strong></li>
                        <li class="moderate"><strong>Entwicklungsverz√∂gerung</strong></li>
                        <li class="moderate"><strong>Rezidivierende Erbrechen/Lethargie</strong></li>
                        <li class="mild">Hypotonie</li>
                        <li class="mild">Gedeihst√∂rung</li>
                    </ul>
                    <div style="margin-top: 15px; padding: 10px; background: rgba(255,255,255,0.7); border-radius: 5px;">
                        <strong>Typisch f√ºr:</strong> MCAD (h√§ufigste Manifestation), prim√§rer Carnitin-Mangel
                    </div>
                </div>
                
                <div class="age-group child">
                    <h3>Kindesalter (1-18 Jahre)</h3>
                    <ul class="symptom-list">
                        <li class="severe"><strong>Belastungsintoleranz</strong></li>
                        <li class="severe"><strong>Rhabdomyolyse bei Anstrengung</strong></li>
                        <li class="moderate"><strong>Myalgie und Muskelschw√§che</strong></li>
                        <li class="moderate"><strong>Episodische Hypoglyk√§mie</strong></li>
                        <li class="moderate"><strong>Rezidivierende Myoglobinurie</strong></li>
                        <li class="mild">Periphere Retinopathie (LCHAD)</li>
                        <li class="mild">Polyneuropathie (LCHAD)</li>
                    </ul>
                    <div style="margin-top: 15px; padding: 10px; background: rgba(255,255,255,0.7); border-radius: 5px;">
                        <strong>Typisch f√ºr:</strong> VLCAD (milde Form), CPT II, sp√§te MCAD-Manifestation
                    </div>
                </div>
                
                <div class="age-group adult">
                    <h3>Erwachsenenalter (>18 Jahre)</h3>
                    <ul class="symptom-list">
                        <li class="severe"><strong>Belastungsmyopathie</strong></li>
                        <li class="severe"><strong>Rhabdomyolyse</strong> bei prolongierter Anstrengung</li>
                        <li class="moderate"><strong>Exercise intolerance</strong></li>
                        <li class="moderate"><strong>Myalgie nach Sport</strong></li>
                        <li class="mild">Muskelschw√§che</li>
                        <li class="mild">Erh√∂hte CK-Werte</li>
                    </ul>
                    <div style="margin-top: 15px; padding: 10px; background: rgba(255,255,255,0.7); border-radius: 5px;">
                        <strong>Typisch f√ºr:</strong> CPT II (myopathische Form), VLCAD (milde Form)
                    </div>
                </div>
            </div>
            
            <div class="emergency-box">
                <h3>Trigger f√ºr metabolische Entgleisungen</h3>
                <ul>
                    <li><strong>Fasten:</strong> >12h S√§uglinge, >16h Kleinkinder, >18h Kinder</li>
                    <li><strong>Fieberhafte Infekte:</strong> Besonders gastrointestinal mit Erbrechen</li>
                    <li><strong>An√§sthesie/Operationen:</strong> Perioperatives Fasten</li>
                    <li><strong>K√∂rperliche Belastung:</strong> Prolongierte Ausdauerbelastung</li>
                    <li><strong>K√§lteexposition:</strong> Erh√∂hter Energiebedarf</li>
                    <li><strong>Schwangerschaft:</strong> Erh√∂hter metabolischer Bedarf</li>
                </ul>
            </div>
            
            <div class="section-header">
                <h2>Diagnostischer Algorithmus</h2>
            </div>
            
            <div class="diagnostic-flowchart">
                <h3>Schrittweise Diagnostik bei Verdacht auf FAO-St√∂rung</h3>
                
                <div class="flowchart-step">
                    <h4>1. Anamnese und klinische Pr√§sentation</h4>
                    <p><strong>Verdachtsmomente:</strong> Hypoketon Hypoglyk√§mie, Familienanamnese, Konsanguinit√§t, auff√§lliges Neugeborenenscreening</p>
                </div>
                
                <div class="flowchart-step decision">
                    <h4>2. Akutdiagnostik (bei metabolischer Krise)</h4>
                    <p><strong>Sofortige Bestimmung:</strong></p>
                    <ul>
                        <li>Blutzucker, Laktat, Blutgase</li>
                        <li>Ammoniak, Transaminasen</li>
                        <li>Ketonk√∂rper (Blut/Urin)</li>
                        <li>CK, Myoglobin (bei Myopathie-Verdacht)</li>
                    </ul>
                </div>
                
                <div class="flowchart-step action">
                    <h4>3. Spezialdiagnostik</h4>
                    <p><strong>Acylcarnitin-Profil (Trockenblut):</strong></p>
                    <ul>
                        <li>Erweitert um freies und Gesamt-Carnitin</li>
                        <li>Bestimmung pathognomischer Metabolite</li>
                        <li>Idealerweise im Fasten-/Krankheitszustand</li>
                    </ul>
                </div>
                
                <div class="flowchart-step action">
                    <h4>4. Erg√§nzende Diagnostik</h4>
                    <p><strong>Organische S√§uren (Urin):</strong></p>
                    <ul>
                        <li>Adipins√§ure, Suberins√§ure (MCAD)</li>
                        <li>Dicarbons√§uren C6-C14 (VLCAD, LCHAD)</li>
                        <li>3-Hydroxydicarbons√§uren (LCHAD)</li>
                    </ul>
                </div>
                
                <div class="flowchart-step warning">
                    <h4>5. Best√§tigungsdiagnostik</h4>
                    <p><strong>Enzymanalytik und/oder Molekulargenetik:</strong></p>
                    <ul>
                        <li>Fibroblastenkultur f√ºr Enzymanalytik</li>
                        <li>Gezielte Sequenzierung bekannter Gene</li>
                        <li>Panel-Diagnostik oder Exom-Sequenzierung</li>
                    </ul>
                </div>
            </div>
            
            <h3>Laborparameter und Interpretation</h3>
            
            <table class="lab-table">
                <thead>
                    <tr>
                        <th>Erkrankung</th>
                        <th>Prim√§re Acylcarnitine</th>
                        <th>Organische S√§uren</th>
                        <th>Besonderheiten</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>MCAD-Mangel</strong></td>
                        <td>C8-Acylcarnitin ‚Üë‚Üë<br>C6, C10:1-Acylcarnitin ‚Üë</td>
                        <td>Adipins√§ure ‚Üë<br>Suberins√§ure ‚Üë<br>Sebacins√§ure ‚Üë</td>
                        <td>C8/C2-Ratio >0,5<br>Hypoketon Hypoglyk√§mie</td>
                    </tr>
                    <tr>
                        <td><strong>VLCAD-Mangel</strong></td>
                        <td>C14:1-Acylcarnitin ‚Üë‚Üë<br>C14, C16, C18:1 ‚Üë</td>
                        <td>Tetradecandis√§ure ‚Üë<br>Lange Dicarbons√§uren ‚Üë</td>
                        <td>C14:1/C2-Ratio >0,03<br>Kardiomyopathie m√∂glich</td>
                    </tr>
                    <tr>
                        <td><strong>LCHAD/TFP-Mangel</strong></td>
                        <td>C16-OH, C18:1-OH ‚Üë‚Üë<br>C16, C18:1 ‚Üë</td>
                        <td>3-OH-Dicarbons√§uren ‚Üë<br>Lange Dicarbons√§uren ‚Üë</td>
                        <td>3-OH-C16:0/C2 >0,01<br>Retinopathie bei LCHAD</td>
                    </tr>
                    <tr>
                        <td><strong>CPT I-Mangel</strong></td>
                        <td>Freies Carnitin ‚Üë‚Üë<br>Gesamt-Acylcarnitine ‚Üì</td>
                        <td>Meist unauff√§llig</td>
                        <td>Ketonurie bei Fasten ‚Üì<br>Hepatomegalie</td>
                    </tr>
                    <tr>
                        <td><strong>CPT II-Mangel</strong></td>
                        <td>C16, C18:1-Acylcarnitin ‚Üë<br>Bei Myopathie oft normal</td>
                        <td>Variable</td>
                        <td>CK ‚Üë‚Üë bei Rhabdomyolyse<br>Myoglobinurie</td>
                    </tr>
                    <tr>
                        <td><strong>Prim√§rer Carnitin-Mangel</strong></td>
                        <td>Freies Carnitin ‚Üì‚Üì<br>(<5 Œºmol/L)</td>
                        <td>Meist unauff√§llig</td>
                        <td>Maternaler Carnitin-Mangel<br>Kardiomyopathie</td>
                    </tr>
                </tbody>
            </table>
            
            <div class="case-study">
                <h3>Fallbeispiel: 8 Monate alter S√§ugling</h3>
                <div class="case-details">
                    <h4>Anamnese:</h4>
                    <p>8 Monate alter S√§ugling wird bewusstlos in der Notaufnahme vorgestellt. Die Eltern berichten √ºber 2-t√§gige Gastroenteritis mit Erbrechen und reduzierter Nahrungsaufnahme. Neugeborenenscreening war unauff√§llig.</p>
                    
                    <h4>Laborwerte:</h4>
                    <ul>
                        <li>Blutzucker: 28 mg/dl (1,6 mmol/L)</li>
                        <li>Ketonk√∂rper (Blut): 0,2 mmol/L (‚Üì)</li>
                        <li>Ammoniak: 145 Œºmol/L (‚Üë)</li>
                        <li>AST: 350 U/L, ALT: 280 U/L</li>
                        <li>CK: 850 U/L</li>
                    </ul>
                    
                    <h4>Acylcarnitin-Profil:</h4>
                    <ul>
                        <li>C8-Acylcarnitin: 8,2 Œºmol/L (‚Üë‚Üë)</li>
                        <li>C10:1-Acylcarnitin: 2,1 Œºmol/L (‚Üë)</li>
                        <li>C8/C2-Ratio: 0,65</li>
                    </ul>
                    
                    <div style="background: #e8f5e8; padding: 15px; border-radius: 5px; margin-top: 15px;">
                        <strong>üéØ Diagnose:</strong> MCAD-Mangel<br>
                        <strong>üí° Lernpunkt:</strong> Hypoketon Hypoglyk√§mie + erh√∂htes C8-Acylcarnitin = MCAD-Mangel bis zum Beweis des Gegenteils
                    </div>
                </div>
            </div>
            
            <div class="differential-box">
                <h3>Differentialdiagnosen</h3>
                
                <div class="differential-item">
                    <h4>Bei hypoketon Hypoglyk√§mie:</h4>
                    <ul>
                        <li><strong>Hyperinsulinismus:</strong> C-Peptid ‚Üë, Insulin ‚Üë</li>
                        <li><strong>Glykogenosen:</strong> Laktat ‚Üë, normale Acylcarnitine</li>
                        <li><strong>Glukoneogenese-Defekte:</strong> Laktat ‚Üë, organische S√§uren auff√§llig</li>
                    </ul>
                </div>
                
                <div class="differential-item">
                    <h4>Bei Myopathie/Rhabdomyolyse:</h4>
                    <ul>
                        <li><strong>Glykogenosen (McArdle, Pompe):</strong> Normale Acylcarnitine</li>
                        <li><strong>Mitochondriopathien:</strong> Laktat ‚Üë, komplexe Enzymdefekte</li>
                        <li><strong>Muskeldystrophien:</strong> Progressive Symptomatik, CK persistiert ‚Üë</li>
                    </ul>
                </div>
                
                <div class="differential-item">
                    <h4>Bei Kardiomyopathie:</h4>
                    <ul>
                        <li><strong>Danon-Erkrankung:</strong> LAMP2-Mutation, Speicher-Myopathie</li>
                        <li><strong>Pompe-Erkrankung:</strong> Œ±-Glucosidase-Mangel, normale Acylcarnitine</li>
                        <li><strong>Barth-Syndrom:</strong> TAZ-Mutation, 3-Methylglutacons√§ure ‚Üë</li>
                    </ul>
                </div>
            </div>
            
            <div class="checklist">
                <h3>Diagnostische Checkliste</h3>
                
                <div class="checklist-item">
                    <input type="checkbox" id="check1">
                    <label for="check1">Familienanamnese auf pl√∂tzlichen Kindstod oder ungekl√§rte Todesf√§lle erhoben</label>
                </div>
                
                <div class="checklist-item">
                    <input type="checkbox" id="check2">
                    <label for="check2">Trigger-Situationen (Fasten, Infekt, Belastung) identifiziert</label>
                </div>
                
                <div class="checklist-item">
                    <input type="checkbox" id="check3">
                    <label for="check3">Acylcarnitin-Profil im symptomatischen Zustand abgenommen</label>
                </div>
                
                <div class="checklist-item">
                    <input type="checkbox" id="check4">
                    <label for="check4">Organische S√§uren im Urin (24h oder Spontanurin) bestimmt</label>
                </div>
                
                <div class="checklist-item">
                    <input type="checkbox" id="check5">
                    <label for="check5">Bei Verdacht auf LCHAD: Ophthalmologische Untersuchung veranlasst</label>
                </div>
                
                <div class="checklist-item">
                    <input type="checkbox" id="check6">
                    <label for="check6">Bei Kardiomyopathie: Echokardiographie und EKG dokumentiert</label>
                </div>
                
                <div class="checklist-item">
                    <input type="checkbox" id="check7">
                    <label for="check7">Geschwister/Familienmitglieder gescreent (bei positiver Diagnostik)</label>
                </div>
                
                <div class="checklist-item">
                    <input type="checkbox" id="check8">
                    <label for="check8">Molekulargenetische Best√§tigung eingeleitet</label>
                </div>
            </div>
            
            <div class="next-section">
                <h3>üîÑ N√§chster Abschnitt</h3>
                <p>Teil 3: Therapie & Notfallmanagement</p>
                <p>Lernen Sie die therapeutischen Strategien, Notfall-Protokolle und Langzeitbetreuung kennen.</p>
            </div>
        </main>
    </div>

    <script>
        // Simple interactivity for checklist
        document.querySelectorAll('.checklist-item input[type="checkbox"]').forEach(checkbox => {
            checkbox.addEventListener('change', function() {
                if (this.checked) {
                    this.parentElement.style.background = 'rgba(76, 175, 80, 0.1)';
                } else {
                    this.parentElement.style.background = 'transparent';
                }
            });
        });
    </script>
</body>
</html>
